High-Density Lipoprotein Mimetics: a Therapeutic Tool for Atherosclerotic Diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High-Density Lipoprotein Mimetics: a Therapeutic Tool for Atherosclerotic Diseases

Published:2016 Issue:4 Volume:23 Page:385-394
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Ikenaga Masahiro¹²,Higaki Yasuki¹²,Saku Keijiro³,Uehara Yoshinari¹²³⁴

Affiliation:

1. Faculty of Sports and Health Science, Fukuoka University

2. The Fukuoka University Institute for Physical Activity, Fukuoka University

3. Department of Cardiology, Fukuoka University School of Medicine

4. Center for Preventive, Anti-aging and Regenerative Medicine, Fukuoka University Hospital

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/jat/23/4/23_33720/_pdf

Reference43 articles.

1. 1) von Eckardstein A, Nofer JR and Assmann G: High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport. Arterioscler Thromb Vasc Biol, 2001; 21: 13-27

2. 2) Gordon T, Castelli WP, Hjortland MC, Kannel WB and Dawber TR: High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med, 1977; 62: 707-714

3. 3) Miyamoto-Sasaki M, Yasuda T, Monguchi T, Nakajima H, Mori K, Toh R, Ishida T and Hirata K: Pitavastatin increases HDL particles functionally preserved with cholesterol efflux capacity and antioxidative actions in dyslipidemic patients. J Atheroscler Thromb, 2013; 20: 708-716

4. 4) Guyton JR, Slee AE, Anderson T, Fleg JL, Goldberg RB, Kashyap ML, Marcovina SM, Nash SD, O'Brien KD, Weintraub WS, Xu P, Zhao XQ and Boden WE: Relationship of lipoproteins to cardiovascular events: the AIM-HIGH Trial (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides and Impact on Global Health Outcomes). J Am Coll Cardiol, 2013; 62: 1580-1584

5. 5) Schwartz GG, Olsson AG, Abt M, Ballantyne CM, Barter PJ, Brumm J, Chaitman BR, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Mundl H, Nicholls SJ, Shah PK, Tardif JC, Wright RS and dal-OUTCOMES Investigators.: Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med, 2012; 367: 2089-2099

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of omega-3 supplementation on glucose and lipid metabolism in patients with gestational diabetes: A meta-analysis of randomized controlled trials;Journal of Diabetes and its Complications;2023-04

2. A Systematic Review of Apolipoprotein A-I Mimetic Peptides for Atherosclerosis Therapy via Activation of the Reverse Cholesterol Transport Pathway;ARYA ATHEROSCLER;2022

3. HDL Mimetic Peptides;HDL Metabolism and Diseases;2022

4. Identification of marine sponge-associated bacteria of the Saint Martin's island of the Bay of Bengal emphasizing on the prevention of motile Aeromonas septicemia in Labeo rohita;Aquaculture;2021-12

5. The Association between Decreased Kidney Function and FIB-4 Index Value, as Indirect Liver Fibrosis Indicator, in Middle-Aged and Older Subjects;International Journal of Environmental Research and Public Health;2021-06-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3